Ulcer Prevention Study in Post Gastric Bypass Patients
Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
This research is to determine which medication, Zegerid (Omeprazole/Sodium Bicarbonate) or
Pepcid AC (Famotidine), works best at reducing the chance that a patient will get an ulcer
after gastric bypass surgery.
Phase:
Phase 4
Details
Lead Sponsor:
University of Missouri-Columbia
Treatments:
Famotidine Omeprazole Omeprazole, sodium bicarbonate drug combination